Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Congenital Abnormalities » Abnormalities, Multiple
Description
Congenital abnormalities that affect more than one organ or body structure. MeSH
Hierarchy View
Subtype Terms (57)
22q11 Deletion Syndrome
7 drugs (6 approved, 1 experimental)
Alagille Syndrome
6 approved drugs
Angelman Syndrome
13 drugs (5 approved, 8 experimental)
Barth Syndrome
2 drugs (1 approved, 1 experimental)
Basal Cell Nevus Syndrome
17 drugs (13 approved, 4 experimental)
Beckwith-Wiedemann Syndrome
8 approved drugs
Carney Complex
1 experimental drug
Cockayne Syndrome
1 approved drug
De Lange Syndrome
1 approved drug
Down Syndrome
68 drugs (54 approved, 14 experimental)
Isolated Noncompaction of the Ventricular Myocardium
Marfan Syndrome
9 approved drugs
Netherton Syndrome
10 drugs (4 approved, 6 experimental)
Nevus, Sebaceous of Jadassohn
1 experimental drug
POEMS Syndrome
9 drugs (7 approved, 2 experimental)
Polycystic Kidney Diseases
18 drugs (14 approved, 4 experimental)
Prader-Willi Syndrome
32 drugs (15 approved, 17 experimental)
Proteus Syndrome
4 drugs (1 approved, 3 experimental)
Rubella Syndrome, Congenital
1 approved drug
Rubinstein-Taybi Syndrome
1 approved drug
Short Rib-Polydactyly Syndrome
Silver-Russell Syndrome
1 approved drug
Smith-Lemli-Opitz Syndrome
6 drugs (3 approved, 3 experimental)
Smith-Magenis Syndrome
3 drugs (2 approved, 1 experimental)
Zellweger Syndrome
7 drugs (6 approved, 1 experimental)
Phase 4 Indicated Drugs (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
